Novel chalcones derived from 2‐chloro‐3‐formyl‐6‐methylquinoline

Molecules of (E)‐3‐(2‐chloro‐6‐methylquinolin‐3‐yl)‐1‐(5‐iodo‐2‐thienyl)prop‐2‐en‐1‐one, C₁₇H₁₁ClINOS, (I), and (E)‐3‐(2‐chloro‐6‐methylquinolin‐3‐yl)‐1‐(5‐methyl‐2‐furyl)prop‐2‐en‐1‐one, C₁₈H₁₄ClNO₂, (II), adopt conformations slightly twisted from coplanarity. Both structures are devoid of classical hydrogen bonds. However, nonclassical C—H...O/N interactions [with C...O = 3.146 (5) Å and C...N = 3.487 (3) Å] link the molecules into chains extended along the b axis in (I) and form dimers with an R₂²(8) motif in (II). The structural analysis of these compounds provides an insight into the correlation between molecular structures and intermolecular interactions in compounds for drug development.     

Channel‐forming solvate crystals and isostructural solvent‐free powder of 5‐hydroxy‐6‐methyl‐2‐pyridone

Crystals of 5‐hydroxy‐6‐methyl‐2‐pyridone, (I), grown from a variety of solvents, are invariably trigonal (space group R); these are 5‐hydroxy‐6‐methyl‐2‐pyridone acetone 0.1667‐solvate, C₆H₇NO₂·0.1667C₃H₆O, (Ia), and 6‐methyl‐5‐hydroxy‐2‐pyridone propan‐2‐ol 0.1667‐solvate, C₆H₇NO₂·0.1667C₃H₈O, (Ib), and the forms from methanol, (Ic), water, (Id), benzonitrile, (Ie), and benzyl alcohol, (If). They incorporate channels running the length of the c axis that contain extensively disordered solvent molecules. A solvent‐free sublimed powder of 5‐hydroxy‐6‐methyl‐2‐pyridone microcrystals is essentially isostructural. Inversion‐related host molecules interact via pairs of N—H...O hydrogen bonds to form R₂²(8) dimers. Six of these dimers form large R₁₂⁶(42) puckered rings, in which the O atom of each N—H...O hydrogen bond is also the acceptor in an O—H...O hydrogen bond that involves the 5‐hydroxy group. The large R₁₂⁶(42) rings straddle the axes and form stacked columns viaπ–π interactions between inversion‐related molecules of (I) [mean interplanar spacing = 3.254 Å and ring centroid–centroid distance = 3.688 (2) Å]. The channels are lined by methyl groups, which all point inwards to the centre of the channels.     

2‐Chloro‐4‐nitrobenzoic acid as a coformer with pharmaceutical cocrystals and molecular salts

A series of five binary complexes, i.e. three cocrystals and two molecular salts, using 2‐chloro‐4‐nitrobenzoic acid as a coformer have been produced with five commonly available compounds, some of pharmaceutical relevance, namely, 2‐chloro‐4‐nitrobenzoic acid–isonicotinamide (1/1), C₇H₄ClNO₄·C₆H₆N₂O, 2‐chloro‐4‐nitrobenzoic acid–3,3‐diethylpyridine‐2,4(1H,3H)‐dione (2/1), 2C₇H₄ClNO₄·C₉H₁₃NO₂, 2‐chloro‐4‐nitrobenzoic acid–pyrrolidin‐2‐one (1/1), C₇H₄ClNO₄·C₄H₇NO, 2‐carboxypiperidinium 2‐chloro‐4‐nitrobenzoate, C₆H₁₂NO₂^?·C₇H₃ClNO₄^?, and (2‐hydroxyethyl)ammonium 2‐chloro‐4‐nitrobenzoate, C₂H₈NO⁺·C₇H₃ClNO₄^?. The coformer falls under the classification of a `generally regarded as safe' compound. All five complexes make use of a number of different heteromeric hydrogen‐bonded interactions. Intermolecular potentials were evaluated using the CSD‐Materials module.     

2:1 Complexes of 2‐chloro‐4‐nitro­benzoic acid and 2‐chloro‐5‐nitro­benzoic acid with pyrazine

2‐Chloro‐4‐nitro­benzoic acid and 2‐chloro‐5‐nitro­benzoic acid form O—H?N hydrogen bonds with pyrazine to afford 2:1 complexes of 2C₇H₄ClNO₄·C₄H₄N₂, (I) and (II), respectively, that are located on inversion centers. The 2C₇H₄ClNO₄·­C₄H₄N₂ units in both complexes are connected by weak C—H?O hydrogen bonds; the units build a three‐dimensional hydrogen‐bond network in (I) and a ribbon structure in (II).     

2‐Ammonio‐5‐chloro‐4‐methylbenzenesulfonate,its 1‐methyl‐2‐pyrrolidone and dimethyl sulfoxide monosolvates and a corrected structure of 2,2′‐(1,4‐phenylene)di(4,5‐dihydroimidazolium) bis(4‐aminobenzenesulfonate) dihydrate

2‐Ammonio‐5‐chloro‐4‐methylbenzenesulfonate, C₇H₈ClNO₃S, (Ia), is an intermediate in the synthesis of lake red azo pigments. The present structure determination from single‐crystal data confirms the results of a previous powder diffraction determination [Bekö, Thoms, Brüning, Alig, van de Streek, Lakatos, Glaubitz & Schmidt (2010). Z. Kristallogr. 225 , 382–387]. The zwitterionic tautomeric form is confirmed. During a polymorph screening, two additional pseudopolymorphs were obtained, viz. 2‐ammonio‐5‐chloro‐4‐methylbenzenesulfonate 1‐methyl‐2‐pyrrolidone monosolvate, C₇H₈ClNO₃S·C₅H₉NO, (Ib), and 2‐ammonio‐5‐chloro‐4‐methylbenzenesulfonate dimethyl sulfoxide monosolvate, C₇H₈ClNO₃S·C₂H₆OS, (Ic). The molecules of (Ib) have crystallographic m symmetry. The 1‐methyl‐2‐pyrrolidone solvent molecule has an envelope conformation and is disordered around the mirror plane. The structure shows hydrogen‐bonded ladders of molecules [graph‐set notation C₂²(6)R₂²(12)] in the [010] direction. The benzene groups of adjacent ladders are also stacked in this direction. A different type of hydrogen‐bonded ladder [graph‐set notation C(6)R₂²(4)R₄⁴(12)] occurs in (Ic). In (Ia), (Ib) and (Ic), the molecules correspond to the zwitterionic tautomer. The structure of the cocrystal of 4‐aminobenzenesulfonic acid with 1,4‐bis(4,5‐dihydroimidazol‐2‐yl)benzene [Shang, Ren, Wang, Lu & Yang (2009). Acta Cryst. E 65 , o2221–o2222] is corrected; it actually contains 4‐aminobenzenesulfonate anions and 2,2′‐(1,4‐phenylene)di(dihydroimidazolium) dications, i.e. 2,2′‐(1,4‐phenylene)di(4,5‐dihydroimidazolium) bis(4‐aminobenzenesulfonate) dihydrate, C₁₂H₁₆N₄²⁺·2C₆H₆NO₃S⁻·2H₂O. Hence, all known structures of aminobenzenesulfonic acid complexes contain ionic or zwitterionic molecules; there is no known structure with a neutral aminobenzenesulfonic acid molecule.     

Supramolecular hydrogen‐bonding patterns in the organic–inorganic hybrid compound bis(4‐amino‐5‐chloro‐2,6‐dimethylpyrimidinium) tetrathiocyanatozinc(II)–4‐amino‐5‐chloro‐2,6‐dimethylpyrimidine–water (1/2/2)

Zinc thiocyanate complexes have been found to be biologically active compounds. Zinc is also an essential element for the normal function of most organisms and is the main constituent in a number of metalloenzyme proteins. Pyrimidine and aminopyrimidine derivatives are biologically very important as they are components of nucleic acids. Thiocyanate ions can bridge metal ions by employing both their N and S atoms for coordination. They can play an important role in assembling different coordination structures and yield an interesting variety of one‐, two‐ and three‐dimensional polymeric metal–thiocyanate supramolecular frameworks. The structure of a new zinc thiocyanate–aminopyrimidine organic–inorganic compound, (C₆H₉ClN₃)₂[Zn(NCS)₄]·2C₆H₈ClN₃·2H₂O, is reported. The asymmetric unit consist of half a tetrathiocyanatozinc(II) dianion, an uncoordinated 4‐amino‐5‐chloro‐2,6‐dimethylpyrimidinium cation, a 4‐amino‐5‐chloro‐2,6‐dimethylpyrimidine molecule and a water molecule. The Zn^II atom adopts a distorted tetrahedral coordination geometry and is coordinated by four N atoms from the thiocyanate anions. The Zn^II atom is located on a special position (twofold axis of symmetry). The pyrimidinium cation and the pyrimidine molecule are not coordinated to the Zn^II atom, but are hydrogen bonded to the uncoordinated water molecules and the metal‐coordinated thiocyanate ligands. The pyrimidine molecules and pyrimidinium cations also form base‐pair‐like structures with an R₂²(8) ring motif via N—H…N hydrogen bonds. The crystal structure is further stabilized by intermolecular N—H…O, O—H…S, N—H…S and O—H…N hydrogen bonds, by intramolecular N—H…Cl and C—H…Cl hydrogen bonds, and also by π–π stacking interactions.     

Hydrogen‐bonded structures of the isomeric compounds of quinoline with 2‐chloro‐5‐nitrobenzoic acid, 3‐chloro‐2‐nitrobenzoic acid, 4‐chloro‐2‐nitrobenzoic acid and 5‐chloro‐2‐nitrobenzoic acid

The structures of four isomeric compounds, all C₇H₄ClNO₄·C₉H₇N, of quinoline with chloro‐ and nitro‐substituted benzoic acid, namely, 2‐chloro‐5‐nitrobenzoic acid–quinoline (1/1), (I), 3‐chloro‐2‐nitrobenzoic acid–quinoline (1/1), (II), 4‐chloro‐2‐nitrobenzoic acid–quinoline (1/1), (III), and 5‐chloro‐2‐nitrobenzoic acid–quinoline (1/1), (IV), have been determined at 185 K. In each compound, a short hydrogen bond is observed between the pyridine N atom and a carboxyl O atom. The N...O distances are 2.6476 (13), 2.5610 (13), 2.5569 (12) and 2.5429 (12) Å for (I), (II), (III) and (IV), respectively. Although in (I) the H atom in the hydrogen bond is located at the O site, in (II), (III) and (IV) the H atom is disordered in the hydrogen bond over two positions with (N site):(O site) occupancies of 0.39 (3):0.61 (3), 0.47 (3):0.53 (3) and 0.65 (3):0.35 (3), respectively.     

Bis(μ‐benzene‐1,2‐dicarboxylato)bis{aqua[2‐(2‐chloro‐6‐fluorophenyl)‐1H‐imidazo[4,5‐f][1,10]phenanthroline]cadmium(II)} and its zinc(II) analogue

In the isomorphous title compounds, [Cd₂(C₈H₄O₄)₂(C₁₉H₁₀ClFN₄)₂(H₂O)₂] and [Zn₂(C₈H₄O₄)₂(C₁₉H₁₀ClFN₄)₂(H₂O)₂], the Cd^II centre is seven‐coordinated by two N atoms from one [2‐(2‐chloro‐6‐fluorophenyl)‐1H‐imidazo[4,5‐f][1,10]phenanthroline (L) ligand, one water O atom and four carboxylate O atoms from two different benzene‐1,2‐dicarboxylate (1,2‐bdc) ligands in a distorted pentagonal–bipyramidal coordination, while the Zn^II centre is six‐coordinated by two N atoms from one L ligand, one water O atom and three carboxylate O atoms from two different 1,2‐bdc ligands in a distorted octahedral coordination. Each pair of adjacent metal centres is bridged by two 1,2‐bdc ligands to form a dimeric structure. In the dimer, each L ligand coordinates one metal centre. The dimer is centrosymmetric, with a crystallographic inversion centre midway between the two metal centres. The aromatic interactions lead the dimers to form a two‐dimensional supramolecular architecture. Finally, O—H...O and N—H...O hydrogen bonds reinforce the two‐dimensional structures of the two compounds.     

Supramolecular architectures in cytosinium 6‐chloronicotinate monohydrate and 5‐bromo‐6‐methylisocytosinium hydrogen sulfate

Aminopyrimidine derivatives are biologically important as they are components of nucleic acids and drugs. The crystals of two new salts, namely cytosinium 6‐chloronicotinate monohydrate, C₄H₆N₃O⁺·C₆H₃ClNO₂⁻·H₂O, ( I ), and 5‐bromo‐6‐methylisocytosinium hydrogen sulfate (or 2‐amino‐5‐bromo‐4‐oxo‐6‐methylpyrimidinium hydrogen sulfate), C₅H₇BrN₃O⁺·HSO₄⁻, ( II ), have been prepared and characterized by single‐crystal X‐ray diffraction. The pyrimidine ring of both compounds is protonated at the imine N atom. In hydrated salt ( I ), the primary R₂²(8) ring motif (supramolecular heterosynthon) is formed via a pair of N—H…O(carboxylate) hydrogen bonds. The cations, anions and water molecule are hydrogen bonded through N—H…O, N—H…N, O—H…O and C—H…O hydrogen bonds, forming R₂²(8), R₃²(7) and R₅⁵(21) motifs, leading to a hydrogen‐bonded supramolecular sheet structure. The supramolecular double sheet structure is formed via water–carboxylate O—H…O hydrogen bonds and π–π interactions between the anions and the cations. In salt ( II ), the hydrogen sulfate ions are linked via O—H…O hydrogen bonds to generate zigzag chains. The aminopyrimidinium cations are embedded between these zigzag chains. Each hydrogen sulfate ion bridges two cations via pairs of N—H…O hydrogen bonds and vice versa, generating two R₂²(8) ring motifs (supramolecular heterosynthon). The cations also interact with one another via halogen–halogen (Br…Br) and halogen–oxygen (Br…O) interactions.     

2‐Amino‐4‐chloro‐5‐formyl‐6‐[methyl(2‐methylphenyl)amino]pyrimidine and 2‐amino‐4‐chloro‐5‐formyl‐6‐[(2‐methoxyphenyl)methylamino]pyrimidine are isostructural and form hydrogen‐bonded sheets of R22(8) and R66(32) rings

2‐Amino‐4‐chloro‐5‐formyl‐6‐[methyl(2‐methylphenyl)amino]pyrimidine, C₁₃H₁₃ClN₄O, (I), and 2‐amino‐4‐chloro‐5‐formyl‐6‐[(2‐methoxyphenyl)methylamino]pyrimidine, C₁₃H₁₃ClN₄O₂, (II), are isostructural and essentially isomorphous. Although the pyrimidine rings in each compound are planar, the ring‐substituent atoms show significant displacements from this plane, and the bond distances provide evidence for polarization of the electronic structures. In each compound, a combination of N—H...N and N—H...O hydrogen bonds links the molecules into sheets built from centrosymmetric R₂²(8) and R₆⁶(32) rings. The significance of this study lies in its observation of the isostructural nature of (I) and (II), and in the comparison of their crystal and molecular structures with those of analogous compounds.     

A novel two‐dimensional cobalt(II) complex composed of one‐dimensional twisted pair‐like chains: poly[[tetraaquabis(μ3‐pyridine‐2,5‐dicarboxylato‐κ4N,O2:O5:O5′)dicobalt(II)] dihydrate]

A novel neutral polymer, {[Co₂(C₇H₃NO₄)₂(H₂O)₄]·2H₂O}_n, was hydrothermally synthesized using pyridine‐2,5‐dicarboxylate (2,5‐PDC²⁻) as the organic linker. It features a two‐dimensional layer structure constructed from one‐dimensional {[Co(2,5‐PDC)₂]²⁻}_n chains interlinked by [Co(H₂O)₄]⁺ units. The two Co^II cations occupy special positions, sitting on inversion centres. Each 2,5‐PDC²⁻ anion chelates to one Co^II cation via the pyridine N atom and an O atom of the adjacent carboxylate group, and links to two other Co^II cations in a bridging mode via the O atoms of the other carboxylate group. In this way, the 2,5‐PDC²⁻ ligand connects three neighbouring Co^II centres to form a two‐dimensional network. The two‐dimensional undulating layers are linked by extensive hydrogen bonds to form a three‐dimensional supramolecular structure, with the uncoordinated solvent molecules occupying the interlamellar region.     

Red,orange and yellow crystals of 4,5‐­bis(4‐methoxy­phenyl)‐2‐(3‐nitro­phenyl)‐1H‐imidazole

Red non‐solvate crystals of the title compound from ethanol, C₂₃H₁₉N₃O₄, orange solvate crystals from tert‐butanol, C₂₃H₁₉N₃O₄·C₄H₁₀O, yellow solvate crystals from dioxane–water, C₂₃H₁₉N₃O₄·0.5C₄H₈O₂, and intense yellow solvate crystals from benzene–N,N′‐dimethylformamide, C₂₃H₁₉N₃O₄·C₆H₆, differ from each other in their molecular conformation and hydrogen‐bonding scheme. The bathochromic shifts of the crystal color are explained by the molecular planarity and charge‐transfer effect among the imidazole mol­ecules.     

Low‐dimensional compounds containing bioactive ligands. IV. Unusual ionic forms of 5‐chloroquinolin‐8‐ol

Bis(5‐chloro‐8‐hydroxyquinolinium) tetrachloridopalladate(II), (C₉H₇ClNO)₂[PdCl₄], (I), catena‐poly[dimethylammonium [[dichloridopalladate(II)]‐μ‐chlorido]], {(C₂H₈N)[PdCl₃]}_n, (II), ethylenediammonium bis(5‐chloroquinolin‐8‐olate), C₂H₁₀N₂²⁺·2C₉H₅ClNO⁻, (III), and 5‐chloro‐8‐hydroxyquinolinium chloride, C₉H₇ClNO⁺·Cl⁻, (IV), were synthesized with the aim of preparing biologically active complexes of Pd^II and Ni^II with 5‐chloroquinolin‐8‐ol (ClQ). Compounds (I) and (II) contain Pd^II atoms which are coordinated in a square‐planar manner by four chloride ligands. In the structure of (I), there is an isolated [PdCl₄]²⁻ anion, while in the structure of (II) the anion consists of Pd^II atoms, lying on centres of inversion, bonded to a combination of two terminal and two bridging Cl⁻ ligands, lying on twofold rotation axes, forming an infinite [–μ₂‐Cl–PdCl₂–]_n chain. The negative charges of these anions are balanced by two crystallographically independent protonated HClQ⁺ cations in (I) and by dimethylammonium cations in (II), with the N atoms lying on twofold rotation axes. The structure of (III) consists of ClQ⁻ anions, with the hydroxy groups deprotonated, and centrosymmetric ethylenediammonium cations. On the other hand, the structure of (IV) consists of a protonated HClQ⁺ cation with the positive charge balanced by a chloride anion. All four structures are stabilized by systems of hydrogen bonds which occur between the anions and cations. π–π interactions were observed between the HClQ⁺ cations in the structures of (I) and (IV).     

Hydrogen‐bonding patterns in 3‐alkyl‐3‐hydroxyindolin‐2‐ones

The molecules of racemic 3‐benzoylmethyl‐3‐hydroxyindolin‐2‐one, C₁₆H₁₃NO₃, (I), are linked by a combination of N—H...O and O—H...O hydrogen bonds into a chain of centrosymmetric edge‐fused R₂²(10) and R₄⁴(12) rings. Five monosubstituted analogues of (I), namely racemic 3‐hydroxy‐3‐[(4‐methylbenzoyl)methyl]indolin‐2‐one, C₁₇H₁₅NO₃, (II), racemic 3‐[(4‐fluorobenzoyl)methyl]‐3‐hydroxyindolin‐2‐one, C₁₆H₁₂FNO₃, (III), racemic 3‐[(4‐chlorobenzoyl)methyl]‐3‐hydroxyindolin‐2‐one, C₁₆H₁₂ClNO₃, (IV), racemic 3‐[(4‐bromobenzoyl)methyl]‐3‐hydroxyindolin‐2‐one, C₁₆H₁₂BrNO₃, (V), and racemic 3‐hydroxy‐3‐[(4‐nitrobenzoyl)methyl]indolin‐2‐one, C₁₆H₁₂N₂O₅, (VI), are isomorphous in space group P. In each of compounds (II)–(VI), a combination of N—H...O and O—H...O hydrogen bonds generates a chain of centrosymmetric edge‐fused R₂²(8) and R₂²(10) rings, and these chains are linked into sheets by an aromatic π–π stacking interaction. No two of the structures of (II)–(VI) exhibit the same combination of weak hydrogen bonds of C—H...O and C—H...π(arene) types. The molecules of racemic 3‐hydroxy‐3‐(2‐thienylcarbonylmethyl)indolin‐2‐one, C₁₄H₁₁NO₃S, (VII), form hydrogen‐bonded chains very similar to those in (II)–(VI), but here the sheet formation depends upon a weak π–π stacking interaction between thienyl rings. Comparisons are drawn between the crystal structures of compounds (I)–(VII) and those of some recently reported analogues having no aromatic group in the side chain.     

Conformational studies of hydantoin‐5‐acetic acid and orotic acid

Hydantoin‐5‐acetic acid [2‐(2,5‐dioxoimidazolidin‐4‐yl)acetic acid] and orotic acid (2,6‐dioxo‐1,2,3,6‐tetrahydropyrimidine‐4‐carboxylic acid) each contain one rigid acceptor–donor–acceptor hydrogen‐bonding site and a flexible side chain, which can adopt different conformations. Since both compounds may be used as coformers for supramolecular complexes, they have been crystallized in order to examine their conformational preferences, giving solvent‐free hydantoin‐5‐acetic acid, C₅H₆N₂O₄, (I), and three crystals containing orotic acid, namely, orotic acid dimethyl sulfoxide monosolvate, C₅H₄N₂O₄·C₂H₆OS, (IIa), dimethylammonium orotate–orotic acid (1/1), C₂H₈N⁺·C₅H₃N₂O₄⁻·C₅H₄N₂O₄, (IIb), and dimethylammonium orotate–orotic acid (3/1), 3C₂H₈N⁺·3C₅H₃N₂O₄⁻·C₅H₄N₂O₄, (IIc). The crystal structure of (I) shows a three‐dimensional network, with the acid function located perpendicular to the ring. Interestingly, the hydroxy O atom acts as an acceptor, even though the carbonyl O atom is not involved in any hydrogen bonds. However, in (IIa), (IIb) and (IIc), the acid functions are only slightly twisted out of the ring planes. All H atoms of the acidic functions are directed away from the rings and, with respect to the carbonyl O atoms, they show an antiperiplanar conformation in (I) and synperiplanar conformations in (IIa), (IIb) and (IIc). Furthermore, in (IIa), (IIb) and (IIc), different conformations of the acid O=C—C—N torsion angle are observed, leading to different hydrogen‐bonding arrangements depending on their conformation and composition.     

(12,17‐Diethoxy­carbonyl‐2,3,6,­7,11,­18‐hexa­methyl­corrphy­cenato‐­κ4N)iodoiron(III) chloro­form solvate

The title complex, (diethyl 3,4,8,15,19,20‐hexa­methyl‐21,22,23,24‐tetraazopenta­cyclo­[16.2.1.1^2,5.1^7,11.1^14,17]­tetracosa‐1(20),2(22),3,5,7,9,11,13(24),14,16,18‐undecaene‐9,14‐dicarb­oxyl­ate‐κ⁴N)­iodo­iron(III) chloro­form solvate, [Fe(C₃₂H₃₂­N₄O₄)I]·­CHCl₃, shows an almost planar arrangement of the corrphycene moiety with a slightly distorted trapezoid pyramidal core; the Fe^III atom is 0.416 (1) Å from the plane of the C₂₀N₄ system. The Fe—N distances are 2.049 (3), 2.044 (3), 2.079 (3) and 2.075 (3) Å. The solvated chloro­form forms a C—H?O hydrogen bond [C?O 3.107 (10) Å] to an adjacent carbonyl O atom. This is the first X‐ray structure analysis of a corrphycenatoiron(III) derivative.     

2‐Pyridone–tartronic acid (1/1), 3‐hydroxy­pyridinium hydrogen tartronate and 4‐hydroxy­pyridinium hydrogen tartronate

Tartronic acid forms a hydrogen‐bonded complex, C₅H₅NO·C₃H₄O₅, (I), with 2‐pyridone, while it forms acid salts, namely 3‐hydroxy­pyridinium hydrogen tartronate, (II), and 4‐hy­droxy­pyridinium hydrogen tartronate, (III), both C₅H₆NO⁺·C₃H₃O₅⁻, with 3‐hydroxy­pyridine and 4‐hydroxy­pyridine, respectively. In (I), the pyridone mol­ecules and the acid mol­ecules form R(8) and R(10) hydrogen‐bonded rings, respectively, around the inversion centres. In (II) and (III), the cations and anions are linked by N—H⋯O and O—H⋯O hydrogen bonds to form a hydrogen‐bonded chain. In each of (I), (II) and (III), an intermolecular hydrogen bond is formed between a carboxyl group and the hydroxyl group attached to the central C atom, and in (I), the hydroxyl group participates in an intramolecular hydrogen bond with a carbonyl group. No intermolecular hydrogen bond is formed between the carboxyl groups in (I), or between the carboxyl and carboxyl­ate groups in (II) and (III).     

Two polymorphs,with Z′ = 1 and 2, of 2‐amino‐4‐chloro‐6‐morpholino­pyrimidine in P21/c,and 2‐amino‐4‐chloro‐6‐piperidino­pyrimidine,which is isomorphous and almost isostructural with the Z′ = 2 polymorph

Crystallization of 2‐amino‐4‐chloro‐6‐morpholino­pyrimidine, C₈H₁₁ClN₄O, (I), yields two polymorphs, both with space group P2₁/c, having Z′ = 1 (from diethyl ether solution) and Z′ = 2 (from di­chloro­methane solution), denoted (Ia) and (Ib), respectively. In polymorph (Ia), the mol­ecules are linked by an N—H⋯O and an N—H⋯N hydrogen bond into sheets built from alternating R(8) and R(40) rings. In polymorph (Ib), one mol­ecule acts as a triple acceptor of hydrogen bonds and the other acts as a single acceptor; one N—H⋯O and three N—H⋯N hydrogen bonds link the mol­ecules in a complex chain containing two types of R(8) and one type of R(18) ring. 2‐Amino‐4‐chloro‐6‐piperidino­pyrimidine, C₉H₁₃ClN₄, (II), which is isomorphous with polymorph (Ib), also has Z′ = 2 in P2₁/c, and the mol­ecules are linked by three N—­H⋯N hydrogen bonds into a centrosymmetric four‐mol­ecule aggregate containing three R(8) rings.     

Poly[di‐μ‐aqua‐μ‐1,2‐bis(pyridin‐4‐yl)ethene‐κ2N:N′‐tetrakis(4‐iodobenzoato‐κ2O,O′)dicadmium]

Colourless crystals of the title compound, [Cd₂(C₇H₄IO₂)₄(C₁₂H₁₀N₂)(H₂O)₂]_n, were obtained by the self‐assembly of Cd(NO₃)₂·4H₂O, 1,2‐bis(pyridin‐4‐yl)ethene (bpe) and 4‐iodobenzoic acid (4‐IBA). Each Cd^II atom is seven‐coordinated in a pentagonal–bipyramidal coordination environment by four carboxylate O atoms from two different 4‐IBA ligands, two O atoms from two water molecules and one N atom from a bpe ligand. The Cd^II centres are bridged by the aqua molecules and bpe ligands, which lie across centres of inversion, to give a two‐dimensional net. Topologically, taking the Cd^II atoms as nodes and the μ‐aqua and μ‐bpe ligands as linkers, the two‐dimensional structure can be simplified as a (6,3) network.     

A chloro(2‐pyridinecarboxaldehyde)(2,2′:6′,2′′‐ter­pyridine)­ruthenium(II) complex

The aldehyde moiety in the title complex, chloro(2‐pyridinecarboxaldehyde‐N,O)(2,2′:6′,2′′‐terpyridine‐κ³N)ruthenium(II)–chloro­(2‐pyridine­carboxyl­ic acid‐N,O)(2,2′:6′,2′′‐ter­pyridine‐κ³N)­ruthenium(II)–perchlorate–chloro­form–water (1.8/0.2/2/1/1), [RuCl­(C₆H₅NO)­(C₁₅H₁₁N₃)]_1.8[RuCl­(C₆H₅­NO₂)(C₁₅H₁₁N₃)]_0.2­(ClO₄)₂·­CHCl₃·­H₂O, is a structural model of substrate coordination to a transfer hydrogenation catalyst. The title complex features two independent Ru^II complex cations that display very similar distorted octahedral coordination provided by the three N atoms of the 2,2′:6′,2′′‐ter­pyridine ligand, the N and O atoms of the 2‐pyridine­carbox­aldehyde (pyCHO) ligand and a chloride ligand. One of the cation sites is disordered such that the aldehyde group is replaced by a 20 (1)% contribution from a carboxyl­ic acid group (aldehyde H replaced by carboxyl O—H). Notable dimensions in the non‐disordered complex cation are Ru—N 2.034 (2) Å and Ru—O 2.079 (2) Å to the pyCHO ligand and O—C 1.239 (4) Å for the pyCHO carbonyl group.